Vontobel Holding Ltd. Astrazeneca PLC Transaction History

Vontobel Holding Ltd.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Jun 03, 2024	BUY	$64.85 - $71.7 $15,499 - $17,136	239 Added 2.91%	8,440 $571,000
Q3 2023 Oct 10, 2023	BUY	$64.85 - $71.7 $15,499 - $17,136	239 Added 2.91%	8,440 $571,000
Q2 2023 Jun 03, 2024	BUY	$69.91 - $75.81 $13,352 - $14,479	191 Added 2.38%	8,201 $586,000
Q2 2023 Jul 24, 2023	BUY	$69.91 - $75.81 $13,352 - $14,479	191 Added 2.38%	8,201 $586,000
Q1 2023 Jun 03, 2024	BUY	$63.15 - $71.6 $505,831 - $573,516	8,010 New	8,010 $555,000
Q1 2023 Apr 12, 2023	BUY	$63.15 - $71.6 $309,750 - $351,198	4,905 Added 157.97%	8,010 $555,000
Q4 2022 Feb 14, 2023	SELL	$54.21 - $70.44 $73,508 - $95,516	-1,356 Reduced 30.4%	3,105 $210,000
Q3 2022 Nov 04, 2022	BUY	$53.02 - $135.75 $71,895 - $184,077	1,356 Added 43.67%	4,461 $245,000
Q2 2022 Jul 27, 2022	BUY	$59.26 - $71.14 $184,002 - $220,889	3,105 New	3,105 $208,000

1,361

475M

5.39M

3.75M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $200B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of Vontobel Holding Ltd., based on Form 13F filings with the SEC.

Stay updated on Vontobel Holding Ltd. with notifications on news.